Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1297, 2010-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
US FDA announces ongoing assessment of CV risk for Stalevo
Reactions Weekly, Vol. 1, Iss. 1316, 2010-01 ,pp. :
Access to resources
Recommend
GnRH agonists: US FDA reviews CV safety
Reactions Weekly, Vol. 1, Iss. 1300, 2010-01 ,pp. :
FDA reviews safety of somatropin
Reactions Weekly, Vol. 1, Iss. 1334, 2011-01 ,pp. :
US FDA reviewing safety of orlistat
Reactions Weekly, Vol. 1, Iss. 1267, 2009-01 ,pp. :
US FDA revises safety advice on albumin administration
Reactions Weekly, Vol. 1, Iss. 1054, 2005-01 ,pp. :